Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID‐19: Design and rationale for the DARE‐19 study

AIMS: Coronavirus disease 2019 (COVID‐19) is caused by a novel severe acute respiratory syndrome coronavirus 2. It can lead to multiorgan failure, including respiratory and cardiovascular decompensation, and kidney injury, with significant associated morbidity and mortality, particularly in patients...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Diabetes Obes Metab
Main Authors: Kosiborod, Mikhail, Berwanger, Otavio, Koch, Gary G., Martinez, Felipe, Mukhtar, Omar, Verma, Subodh, Chopra, Vijay, Javaheri, Ali, Ambery, Philip, Gasparyan, Samvel B., Buenconsejo, Joan, Sjöström, C. David, Langkilde, Anna Maria, Oscarsson, Jan, Esterline, Russell
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Publishing Ltd 2021
Fag:
Clinical Trial Design
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8049025/
https://ncbi.nlm.nih.gov/pubmed/33319454
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.14296
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker